Literature DB >> 16361599

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome.

C J M Frijns1, R Fijnheer, A Algra, J A van Mourik, J van Gijn, G J E Rinkel.   

Abstract

OBJECTIVE: To investigate the relation of endothelial cell activation with delayed cerebral ischaemia (DCI) and outcome after subarachnoid haemorrhage (SAH).
METHODS: Concentrations of soluble (s) intercellular adhesion molecule-1, sE-selectin, sP-selectin, ED1-fibronectin, von Willebrand Factor (vWf), and vWf propeptide were measured within three days of SAH onset. The associations with poor outcome were investigated at three months in 106 patients. In 90 patients in whom the occurrence of cerebral ischaemia could be dated accurately, two analyses were undertaken: one for all ischaemic events (n = 32), including those related to treatment, and another for spontaneous DCI (n = 11). Concentrations of markers were dichotomised at their medians. The associations of endothelial cell activation markers with outcome were expressed as odds ratios (OR) from logistic regression and those with ischaemic events as hazard ratios (HR) derived from Cox regression.
RESULTS: Early vWf concentrations were associated with poor outcome (crude OR = 4.6 (95% CI, 2.0 to 10.9; adjusted OR = 3.3 (1.1 to 9.8). Early levels of vWf were also positively related to occurrence of all ischaemic events (crude HR = 2.3 (1.1 to 4.9); adjusted HR = 1.8 (0.8 to 3.9) and with occurrence of spontaneous DCI (crude HR = 3.5 (0.9 to 13.1); adjusted HR = 2.2 (0.5 to 9.8). None of the other markers showed any associations.
CONCLUSIONS: Concentrations of sICAM-1, sP-selectin, sE-selectin, and ED1-fibronectin do not predict the occurrence of DCI or outcome. The positive associations of raised early vWf concentrations with ischaemic events and poor outcome after SAH may reflect a predisposition to further ischaemic injury through formation of microthrombi in the cerebral circulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16361599      PMCID: PMC2117384          DOI: 10.1136/jnnp.2005.064956

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm.

Authors:  A K Sills; R E Clatterbuck; R C Thompson; P L Cohen; R J Tamargo
Journal:  Neurosurgery       Date:  1997-08       Impact factor: 4.654

2.  Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats.

Authors:  E M Oshiro; P A Hoffman; G N Dietsch; M C Watts; D M Pardoll; R J Tamargo
Journal:  Stroke       Date:  1997-10       Impact factor: 7.914

3.  Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage.

Authors:  Y Hirashima; S Nakamura; S Endo; N Kuwayama; Y Naruse; A Takaku
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

Review 4.  von Willebrand factor: a marker of endothelial damage?

Authors:  P M Mannucci
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

5.  Vasospasm diagnosis: theoretical and real transcranial Doppler sensitivity.

Authors:  P Creissard; F Proust; O Langlois
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation.

Authors:  J A van Mourik; R Boertjes; I A Huisveld; K Fijnvandraat; D Pajkrt; P J van Genderen; R Fijnheer
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

Review 7.  Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review.

Authors:  J W Hop; G J Rinkel; A Algra; J van Gijn
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

8.  Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.

Authors:  M Bavbek; R Polin; A L Kwan; A S Arthur; N F Kassell; K S Lee
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

9.  Cisternal CSF levels of cytokines after subarachnoid hemorrhage.

Authors:  P Gaetani; F Tartara; P Pignatti; F Tancioni; R Rodriguez y Baena; F De Benedetti
Journal:  Neurol Res       Date:  1998-06       Impact factor: 2.448

10.  Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage.

Authors:  R S Polin; M Bavbek; M E Shaffrey; K Billups; C A Bogaev; N F Kassell; K S Lee
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

View more
  23 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

2.  Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage.

Authors:  Dominic A Siler; Yosef A Berlow; Ayaka Kukino; Catherine M Davis; Jonathan W Nelson; Marjorie R Grafe; Hirohisa Ono; Justin S Cetas; Martin Pike; Nabil J Alkayed
Journal:  Stroke       Date:  2015-05-19       Impact factor: 7.914

3.  The changes of von willebrand factor/a disintegrin-like and metalloprotease with thrombospondin type I repeats-13 balance in aneurysmal subarachnoid hemorrhage.

Authors:  Qi-Feng Tang; Shi-Qi Lu; Yi-Ming Zhao; Jin-Xian Qian
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage.

Authors:  C J M Frijns; K M Kasius; A Algra; R Fijnheer; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

5.  Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage.

Authors:  Khalid A Hanafy; Bartosz Grobelny; Luis Fernandez; Pedro Kurtz; E S Connolly; Stephan A Mayer; Christian Schindler; Neeraj Badjatia
Journal:  J Neurol Sci       Date:  2010-01-27       Impact factor: 3.181

Review 6.  Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review.

Authors:  Jacoline Boluijt; Joost C M Meijers; Gabriel J E Rinkel; Mervyn D I Vergouwen
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-18       Impact factor: 6.200

Review 7.  Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.

Authors:  Julia C Durrant; Holly E Hinson
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

8.  Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Mervyn D I Vergouwen; Nan van Geloven; Rob J de Haan; Nyika D Kruyt; Marinus Vermeulen; Yvo B W E M Roos
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

Review 9.  Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review.

Authors:  Caron M Hong; Cigdem Tosun; David B Kurland; Volodymyr Gerzanich; David Schreibman; J Marc Simard
Journal:  Biomarkers       Date:  2014-02-05       Impact factor: 2.658

10.  TNF-alpha and sICAM-1 in intracranial aneurismal rupture.

Authors:  Anna Maria Witkowska; Maria Halina Borawska; Katarzyna Socha; Jan Kochanowicz; Zenon Mariak; Maria Konopka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-04-02       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.